Submission of Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter ended on June 30, 2025

Revenue growth above 20%Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-40.2%Reaction day

₹38.77

prior close

₹23.19

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.1%-38.1% vs market

Dairy Products peers, median of 9sector-2.4%-37.8% vs sector

On the reaction day the stock moved 38.1 pts less than Nifty Microcap 250 and 37.8 pts less than its Dairy Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.0

15m

-0.0

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-40.2-2.1-38.1-2.4-37.8

Next day

-43.2-2.9-40.2-3.0-40.1

-46.0-3.3-42.7-2.2-43.8

-48.7-2.0-46.7-0.6-48.1

-51.3-0.7-50.6+0.0-51.3

-53.7-1.0-52.7+0.5-54.2

-58.2-1.5-56.7-1.0-57.2

15d

-53.7-0.3-53.4-3.2-50.5

-56.4+0.3-56.7-0.8-55.6

-62.1-1.8-60.3-3.4-58.6

-64.7-5.3-59.4-10.7-54.0

UpDownMarket · Nifty Microcap 250Sector · Dairy Products peers, median of 9Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Healthy Life Agritec Ltd's Board approved unaudited Q1 FY26 results on September 25, 2025. Standalone revenue from operations rose to Rs. 1,667.70 lakhs, up about 21.6% from Rs. 1,371.23 lakhs in Q1 FY25, while standalone profit after tax grew to Rs. 47.52 lakhs (vs Rs. 38.88 lakhs). Consolidated revenue climbed to Rs. 4,276.33 lakhs (vs Rs. 3,465.87 lakhs, ~23.4% YoY growth), with consolidated PAT at Rs. 82.98 lakhs versus Rs. 68.45 lakhs in the year-ago quarter. EPS stood at Rs. 0.19 (standalone) and Rs. 0.33 (consolidated). Statutory auditor NYS & Company issued an unqualified limited review report with no qualifications or observations. The results were also filed for inclusion in the Letter of Offer for the company's upcoming Rights Issue, scheduled to open on October 7, 2025.

Likely market impact

Topline growth above 20% YoY at both standalone and consolidated levels signals healthy demand momentum ahead of the Rights Issue opening October 7, 2025; shareholders should expect potential dilution but also fresh capital for the company. Margins remain thin (~2.6-3.8% PBT margin) given the trading nature of the business, so profitability improvement will be the key thing to watch.